share_log

CVS Health | 8-K: Current report

CVS Health | 8-K: Current report

西维斯健康 | 8-K:重大事件
美股SEC公告 ·  12/02 22:55

Moomoo AI 已提取核心信息

On December 2, 2024, CVS Health announced cash tender offers for its 4.100% Senior Notes due 2025 and other series of notes, including those issued by Aetna. The total purchase price for these offers will not exceed $2 billion, excluding accrued interest. The tender offers aim to retire a portion of CVS Health's outstanding debt.The Any and All Notes tender offer expires on December 6, 2024, while the Maximum Tender Offer Notes have an early tender date of December 13, 2024, and a final expiration date of December 31, 2024. CVS Health plans to fund these offers with proceeds from new subordinated debt securities.Barclays Capital Inc. and Mizuho Securities USA LLC are acting as Dealer Managers for the tender offers, with D.F. King & Co., Inc. as the Tender and Information Agent.
On December 2, 2024, CVS Health announced cash tender offers for its 4.100% Senior Notes due 2025 and other series of notes, including those issued by Aetna. The total purchase price for these offers will not exceed $2 billion, excluding accrued interest. The tender offers aim to retire a portion of CVS Health's outstanding debt.The Any and All Notes tender offer expires on December 6, 2024, while the Maximum Tender Offer Notes have an early tender date of December 13, 2024, and a final expiration date of December 31, 2024. CVS Health plans to fund these offers with proceeds from new subordinated debt securities.Barclays Capital Inc. and Mizuho Securities USA LLC are acting as Dealer Managers for the tender offers, with D.F. King & Co., Inc. as the Tender and Information Agent.
2024年12月2日,CVS Health宣布了其2025年到期的4.100%优先票据和其他系列票据(包括安泰发行的票据)的现金要约。不包括应计利息,这些优惠的总购买价格不会超过20亿美元。招标要约旨在偿还CVS Health的部分未偿债务。所有票据的要约将于2024年12月6日到期,而最高投标要约票据的提前投标日期为2024年12月13日,最终到期日为2024年12月31日。CVS Health计划用新的次级债务证券的收益为这些要约提供资金。巴克莱资本公司和瑞穗证券美国有限责任公司担任要约的交易商经理,D.F. King & Co., Inc.担任投标和信息代理人。
2024年12月2日,CVS Health宣布了其2025年到期的4.100%优先票据和其他系列票据(包括安泰发行的票据)的现金要约。不包括应计利息,这些优惠的总购买价格不会超过20亿美元。招标要约旨在偿还CVS Health的部分未偿债务。所有票据的要约将于2024年12月6日到期,而最高投标要约票据的提前投标日期为2024年12月13日,最终到期日为2024年12月31日。CVS Health计划用新的次级债务证券的收益为这些要约提供资金。巴克莱资本公司和瑞穗证券美国有限责任公司担任要约的交易商经理,D.F. King & Co., Inc.担任投标和信息代理人。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息